This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection | MicrobiomeTrials
← Back to trials NCT07706686
Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-07-30Est. Completion: 2028-11-03
Enrollment target: 200 participantsLocations National Institutes of Health Clinical Center, Bethesda, Maryland, United States Other microbiome trials you might be interested in Dry Eye Disease
This study aims to evaluate the performance of biomarkers and their responsiveness to standard-of-care treatments (Vevye…
Newport Beach, United States Completed Jul 16, 2026
Healthy
The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healt…
Biberach, Germany Est. completion Jul 24, 2026